British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease

Elizabeth J. Price; Stuart Benjamin; Michele Bombardieri; Simon Bowman; Sara Carty; Coziana Ciurtin; Bridget Crampton; Annabel Dawson; Benjamin A. Fisher; Ian Giles; Peter Glennon; Monica Gupta; Katie L. Hackett; Genevieve Larkin; Wan Fai Ng; Athimalaipet V. Ramanan; Saad Rassam; Saaeha Rauz; Guy Smith; Nurhan Sutcliffe; Anwar Tappuni; Stephen B. Walsh

doi:10.1093/rheumatology/keae152

British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease

Elizabeth J. Price
, Stuart Benjamin
, Michele Bombardieri
, Simon Bowman
, Sara Carty
, Coziana Ciurtin
, Bridget Crampton
, Annabel Dawson
, Benjamin A. Fisher
, Ian Giles
, Peter Glennon
, Monica Gupta
, Katie L. Hackett
, Genevieve Larkin
, Wan Fai Ng
, Athimalaipet V. Ramanan
, Saad Rassam
, Saaeha Rauz
, Guy Smith
, Nurhan Sutcliffe

Anwar Tappuni, Stephen B. Walsh

Research output: Contribution to journal › Article › peer-review

Abstract

Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition - conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams.

Original language	English
Pages (from-to)	409-439
Number of pages	31
Journal	Rheumatology
Volume	64
Issue number	2
DOIs	https://doi.org/10.1093/rheumatology/keae152
Publication status	Published - 1 Feb 2025
Externally published	Yes

Keywords

connective tissue disease
guideline
management
recommendations
Sjögren disease
Sjögren's syndrome
treatment

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/rheumatology/keae152

Cite this

Price, E. J., Benjamin, S., Bombardieri, M., Bowman, S., Carty, S., Ciurtin, C., Crampton, B., Dawson, A., Fisher, B. A., Giles, I., Glennon, P., Gupta, M., Hackett, K. L., Larkin, G., Ng, W. F., Ramanan, A. V., Rassam, S., Rauz, S., Smith, G., ... Walsh, S. B. (2025). British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease. Rheumatology, 64(2), 409-439. https://doi.org/10.1093/rheumatology/keae152

@article{43f03335c80440d78825db2b7fb4c1cf,

title = "British Society for Rheumatology guideline on management of adult and juvenile onset Sj{\"o}gren disease",

abstract = "Sj{\"o}gren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition - conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams.",

keywords = "connective tissue disease, guideline, management, recommendations, Sj{\"o}gren disease, Sj{\"o}gren's syndrome, treatment",

author = "Price, \{Elizabeth J.\} and Stuart Benjamin and Michele Bombardieri and Simon Bowman and Sara Carty and Coziana Ciurtin and Bridget Crampton and Annabel Dawson and Fisher, \{Benjamin A.\} and Ian Giles and Peter Glennon and Monica Gupta and Hackett, \{Katie L.\} and Genevieve Larkin and Ng, \{Wan Fai\} and Ramanan, \{Athimalaipet V.\} and Saad Rassam and Saaeha Rauz and Guy Smith and Nurhan Sutcliffe and Anwar Tappuni and Walsh, \{Stephen B.\}",

note = "Publisher Copyright: {\textcopyright} 2024 The Author(s). Published by Oxford University Press on behalf of the British Society for Rheumatology.",

year = "2025",

month = feb,

day = "1",

doi = "10.1093/rheumatology/keae152",

language = "English",

volume = "64",

pages = "409--439",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "2",

}

Price, EJ, Benjamin, S, Bombardieri, M, Bowman, S, Carty, S, Ciurtin, C, Crampton, B, Dawson, A, Fisher, BA, Giles, I, Glennon, P, Gupta, M, Hackett, KL, Larkin, G, Ng, WF, Ramanan, AV, Rassam, S, Rauz, S, Smith, G, Sutcliffe, N, Tappuni, A & Walsh, SB 2025, 'British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease', Rheumatology, vol. 64, no. 2, pp. 409-439. https://doi.org/10.1093/rheumatology/keae152

TY - JOUR

T1 - British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease

AU - Price, Elizabeth J.

AU - Benjamin, Stuart

AU - Bombardieri, Michele

AU - Bowman, Simon

AU - Carty, Sara

AU - Ciurtin, Coziana

AU - Crampton, Bridget

AU - Dawson, Annabel

AU - Fisher, Benjamin A.

AU - Giles, Ian

AU - Glennon, Peter

AU - Gupta, Monica

AU - Hackett, Katie L.

AU - Larkin, Genevieve

AU - Ng, Wan Fai

AU - Ramanan, Athimalaipet V.

AU - Rassam, Saad

AU - Rauz, Saaeha

AU - Smith, Guy

AU - Sutcliffe, Nurhan

AU - Tappuni, Anwar

AU - Walsh, Stephen B.

PY - 2025/2/1

Y1 - 2025/2/1

N2 - Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition - conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams.

AB - Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition - conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams.

KW - connective tissue disease

KW - guideline

KW - management

KW - recommendations

KW - Sjögren disease

KW - Sjögren's syndrome

KW - treatment

UR - https://www.scopus.com/pages/publications/85217096861

U2 - 10.1093/rheumatology/keae152

DO - 10.1093/rheumatology/keae152

M3 - Article

C2 - 38621708

AN - SCOPUS:85217096861

SN - 1462-0324

VL - 64

SP - 409

EP - 439

JO - Rheumatology

JF - Rheumatology

IS - 2

ER -

British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this